Heidi Ammerlaan

Convalescent Plasma for COVID-19. A randomized clinical trial

Arvind Gharbharan, Carlijn Jordans, Corine H. GeurtsvanKessel et al. · 2020 · 237 citations · Full text

Vaccination, Immunohematology, Structured Abstract +14

Secular Trends in Nosocomial Bloodstream Infections: Antibiotic-Resistant Bacteria Increase the Total Burden of Infection

Heidi Ammerlaan, Stephan Harbarth, A. G. M. Buiting et al. · Clinical Infectious Diseases · 2012 · 177 citations · Full text

Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection

Arvind Gharbharan, Carlijn Jordans, Corine H. GeurtsvanKessel et al. · Nature Communications · 2021 · 158 citations · Full text

Adequacy of Antimicrobial Treatment and Outcome of<i>Staphylococcus aureus</i>Bacteremia in 9 Western European Countries

Heidi Ammerlaan, Harald Seifert, Stéphan Harbarth et al. · Clinical Infectious Diseases · 2009 · 98 citations · Full text

COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study

Sheryl Ann Abdukahil, Ryuzo Abe, Laurent Abel et al. · Infection · 2021 · 80 citations · Full text